<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>19(10)</volume><submitter>Kari V</submitter><journal>EMBO reports</journal><pagination>e46783</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6172452</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Loss of CHD1 causes DNA repair defects and enhances prostate cancer therapeutic responsiveness.</pubmed_title><pmcid>PMC6172452</pmcid><pubmed_authors>Baumgart SJ</pubmed_authors><pubmed_authors>Dikomey E</pubmed_authors><pubmed_authors>Johnsen SA</pubmed_authors><pubmed_authors>Sirma H</pubmed_authors><pubmed_authors>Kari V</pubmed_authors><pubmed_authors>Raul SK</pubmed_authors><pubmed_authors>Will H</pubmed_authors><pubmed_authors>Mund A</pubmed_authors><pubmed_authors>Dobbelstein M</pubmed_authors><pubmed_authors>Grade M</pubmed_authors><pubmed_authors>Mansour WY</pubmed_authors><pubmed_authors>Simon R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Loss of CHD1 causes DNA repair defects and enhances prostate cancer therapeutic responsiveness.</name><description/><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Oct</publication><modification>2025-04-04T08:41:30.421Z</modification><creation>2025-04-04T08:41:30.421Z</creation></dates><accession>S-EPMC6172452</accession><cross_references><pubmed>30291165</pubmed><doi>10.15252/embr.201846783</doi></cross_references></HashMap>